Aspen is now also considering the possibility of an initial public offering next year in an effort to bring its cell therapy ...

Please provide your email address to receive an email when new articles are posted on . Aviceda Therapeutics secured $207.5 million in Series C financing to advance the AVD-104 program in geographic ...

An announcement from Ascelia Pharma AB ( ($SE:ACE) ) is now available. Ascelia Pharma’s Board of Directors has decided to convert 53,335 series C ...